Related Experiment Video
Updated: Feb 1, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer
Jingjie Li1, Bin Hu1,2, Ting Wang3
1The Institute of Cell Metabolism, Shanghai Key Laboratory of Pancreatic Disease, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200080, China.
Background:
Chromatin modification at mitosis is closely related to transcriptional reactivation in the subsequent cell cycle. We reasoned this process is deregulated by oncogenic signals, which would contribute to mitotic stress resistance in pancreatic cancer. Here, we show DMAP1/Bub3 complex mediates mitotic stress-induced cellular apoptosis, while this effect is counteracted by c-Src in pancreatic cancer cells. Our study aims to uncover an unidentified mechanism underlying the distinct response to mitotic stress between normal cells and pancreatic cancer cells.
Methods:
The interaction between Bub3 and DMAP1 upon mitotic stress signaling was determined through molecular and cell biological methods. The inhibitory effect of c-Src on DMAP1/Bub3-mediated DNA methylation and gene transcription profile was investigated. The association between c-Src-mediated DMAP1 phosphorylation and paclitaxel activity in vivo and clinicopathologic characteristics were analyzed.
Results:
Mitotic arrest induced p38-dependent phosphorylation of Bub3 at Ser211, which promotes DMAP1/Bub3 interaction. DMAP1/Bub3 complex is recruited by TAp73 to the promoter of anti-apoptotic gene BCL2L1, thus mediates the DNA methylation and represses gene transcription linked to cell apoptosis. Meanwhile, DMAP1 was highly phosphorylated at Tyr 246 by c-Src in pancreatic cancer cells, which impedes DMAP1/Bub3 interaction and the relevant cellular activites. Blocking DMAP1 pTyr-246 potentiates paclitaxel-inhibited tumor growth. Clinically, DMAP1 Tyr 246 phosphorylation correlates with c-Src activity in human pancreatic cancer specimens and poor prognosis in pancreatic cancer patients.
Conclusions:
Our findings reveal a regulatory role of Bub3 in DMAP1-mediated DNA methylation upon mitotic stress and provide the relevance of DMAP1 pTyr-246 to mitotic stress resistance during pancreatic cancer treatment.
Insights
DMAP1/Bub3 complex normally triggers apoptosis after mitotic stress, but c-Src in pancreatic cancer blocks this. Targeting DMAP1 phosphorylation enhances cancer treatment efficacy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Epigenetics
Background:
- Chromatin modification during mitosis is crucial for cell cycle progression and is often dysregulated in cancer.
- Oncogenic signals can promote resistance to mitotic stress, a hallmark of pancreatic cancer.
- The distinct responses to mitotic stress between normal and cancerous cells remain incompletely understood.
Purpose of the Study:
- To elucidate the mechanism by which pancreatic cancer cells resist mitotic stress.
- To investigate the role of the DMAP1/Bub3 complex in mediating apoptosis upon mitotic stress.
- To determine how c-Src signaling counteracts DMAP1/Bub3-mediated apoptosis in pancreatic cancer.
Main Methods:
- Utilized molecular and cell biology techniques to study DMAP1/Bub3 interactions under mitotic stress.
- Investigated the impact of c-Src on DMAP1/Bub3-mediated DNA methylation and gene transcription.
- Analyzed the correlation between c-Src-mediated DMAP1 phosphorylation, in vivo paclitaxel activity, and clinicopathologic features.
Main Results:
- Mitotic arrest induces p38-dependent Bub3 phosphorylation, promoting DMAP1/Bub3 complex formation and recruitment to the BCL2L1 promoter, leading to DNA methylation and repression of apoptosis.
- In pancreatic cancer cells, c-Src phosphorylates DMAP1 at Tyr 246, disrupting DMAP1/Bub3 interaction and inhibiting apoptosis.
- Inhibition of DMAP1 Tyr 246 phosphorylation enhances paclitaxel's anti-tumor effects, and this phosphorylation correlates with c-Src activity and poor prognosis in patients.
Conclusions:
- Bub3 plays a regulatory role in DMAP1-mediated DNA methylation in response to mitotic stress.
- DMAP1 phosphorylation at Tyr 246 is a key factor in mitotic stress resistance in pancreatic cancer.
- Targeting DMAP1 pTyr-246 represents a potential therapeutic strategy to overcome treatment resistance in pancreatic cancer.
Related Concept Videos
Formation of Complex Ions
Treatment Resistant Cancers
Responses to Salt Stress
The Mitotic Spindle
The bipolar configuration of the mitotic spindle facilitates chromosomal segregation, preparing the cell for division. One mechanism that ensures...
Feedback Inhibition
Responses to Heat and Cold Stress

